They Just Don't Get...
Health Care: Drugs
Depomed Inc. (DEPO: NASDAQ)
$5.01 0.01 | 0.20%
06/04/12 - 12:14 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 24.04M | 22.53M | 26.82M | 22.13M |
| Receivables | 12.56M | 6.35M | 4.93M | 3.68M |
| Inventories | 5.40M | 1.57M | 2.56M | 2.85M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 109.49M | 79.60M | 78.43M | 93.99M |
| Property, Plant & Equipment, Gross | 9.42M | 8.83M | 8.97M | 8.38M |
| Accumulated Depreciation & Depletion | 8.35M | 8.13M | 8.03M | 7.48M |
| Property, Plant & Equipment, Net | 1.07M | 698.00K | 942.00K | 900.00K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 53.81M | 6.73M | 12.21M | 197.00K |
| Total Non-Current Assets | 54.88M | 7.43M | 13.16M | 1.10M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 164.37M | 87.03M | 91.58M | 95.08M |
| Accounts Payable | 2.42M | 18.47M | 4.07M | 559.00K |
| Short Term Debt | 0.00 | 2.17M | 3.75M | 3.36M |
| Other Current Liabilities | 64.00K | 635.00K | 414.00K | 1.81M |
| Total Current Liabilities | 39.84M | 32.98M | 32.20M | 22.38M |
| Long Term Debt | 0.00 | 0.00 | 2.17M | 5.78M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 18.61M | 30.94M | 41.48M | 33.78M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 18.61M | 30.94M | 43.65M | 39.55M |
| Total Liabilities | 58.45M | 63.92M | 75.86M | 61.93M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 105.92M | 23.11M | 15.73M | 33.15M |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 203.51M | 191.34M | 187.90M | 183.20M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -97.58M | -168.31M | -172.20M | 0.00 |
| Treasury Stock | 0.00 | 0.00 | 0.00 | -150.19M |
| Other Equity Adjustments | -13.00K | 69.00K | 33.00K | 151.00K |
| Total Capitalization | 105.92M | 23.11M | 17.90M | 38.93M |
| Total Equity | 105.92M | 23.11M | 15.73M | 33.15M |
| Total Liabilities & Stock Equity | 164.37M | 87.03M | 91.58M | 95.08M |
| Total Common Shares Outstanding | 55.51M | 52.96M | 52.20M | 51.17M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 54.56M | 52.53M | 51.52M | 48.78M |
| Diluted Weighted Shares Outstanding | 56.09M | 53.46M | 51.52M | 48.78M |
| Number of Employees | 110 | 69 | 73 | 81 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with DEPO
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- Usertracking
- UserAccelerant
- UserRASHID 1
- UserPortfolio 02
- UserJan Jan Portfolio 1
- Contributor10 Surging Stocks Most at R...
- Usergbwineman Portfolio 1
- UserLTR7181 Portfolio 1
- Userfrankie'spicks
Latest DEPO Headlines from TheStreet
- Stocks Under $10: Healthcare Name on Sale
05.17.12 | 07:05 am - Depomed: After-Hours Trading 02.03.12 | 05:02 pm
- Depomed Stock Hits New 52-Week Low (DEPO) 10.18.11 | 10:10 am
- Depomed Stock Gaps Down On Today's Open (DEPO) 10.14.11 | 09:10 am
- 7 Stocks to Watch: Google, Apple 10.14.11 | 07:10 am
- Google, Depomed: After-Hours Trading 10.13.11 | 05:10 pm
- Acadia Pharmaceuticals: Investing With No Safety Net 06.24.11 | 10:06 am
- Biotech Stock Mailbag: Star Scientific 03.18.11 | 07:03 am
- 5 Stocks to Watch: Sanmina, UBS 03.17.11 | 07:03 am
- Guess?, DepoMed: After-Hours Trading 03.16.11 | 05:03 pm
Press Releases for DEPO
- Depomed Announces Filing Of Shelf Registration To Replace Existing Shelf - PR Newswire 05.29.12 | 08:05 am
- Depomed To Present At Jefferies 2012 Global Health Care Conference - PR Newswire 05.25.12 | 08:05 am
- Depomed To Present At Bank Of America Merrill Lynch 2012 Health Care Conference - PR Newswire 05.10.12 | 08:05 am
- New 60,000 Square Foot Lease At The Pacific Research Center Signed By Biomed Realty And Depomed - PR Newswire 04.09.12 | 04:04 pm
- Santarus And Depomed Announce Settlement With Lupin Of GLUMETZA Patent Litigation - Business Wire 02.22.12 | 04:02 pm
- Santarus And Depomed Announce New U.S. Commercialization Agreement For GLUMETZA Prescription Products - Business Wire 08.22.11 | 05:08 am
- Ironwood Pharmaceuticals And Depomed Announce Collaboration, Research And License Agreement - Business Wire 07.27.11 | 04:07 pm
- Santarus And Depomed Announce Availability Of GLUMETZA 500 Mg Tablets - Business Wire 01.05.11 | 04:01 am
- New Clinical Study Shows Patients With Type 2 Diabetes May Be Able To Tolerate Higher Doses Of Metformin Using GLUMETZA - PR Newswire 06.28.10 | 08:06 am
- Depomed To Present At The 9th Annual JMP Securities Research Conference - Business Wire 05.04.10 | 08:05 am
Partner Headlines for DEPO
- New Constructs' Most Attractive Stocks for June - Benzinga 06.04.12 | 09:06 am
- The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Shire, Depomed, Comcast and Microsoft - Press Releases - Zacks 05.18.12 | 09:05 am
- Company News for February 7, 2012 - Corporate Summary - Zacks 02.07.12 | 10:02 am
- 7 Healthcare Stocks Undervalued By Earnings Growth And Cash Flows - Seeking Alpha 02.03.12 | 07:02 pm
- Depomed Announces FDA Approval of Merck's JANUMET XR That Accesses Depomed Patents Licensed to Merck - Benzinga 02.03.12 | 04:02 pm
- Depomed Receives Notice of Paragraph IV Certification Against Patents for Gralise - Benzinga 01.23.12 | 04:01 pm
- BMS Drug Deemed Too Costly: Weekly Round-Up Of Biotech Failures And Mishaps - Seeking Alpha 10.16.11 | 08:10 am
- UPDATE: Zacks Upgrades DepoMed from Neutral to Outperform - Benzinga 08.10.11 | 09:08 am
- 5 Highly Profitable Stocks Undervalued by EPS Trends - Seeking Alpha 07.11.11 | 06:07 am
- Contrarian Ideas: 25 High Growth Stocks With Significant Short Selling - Seeking Alpha 06.06.11 | 08:06 am
